Clinical Trials in San Antonio

Showing 9941-9960 of 12,572 trials

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis

NCT00790023

To demonstrate the efficacy of ciclesonide HFA applied as a nasal aerosol (160 μg and 80 μg) once daily compared to placebo in subjects with SAR.

Seasonal Allergic Rhinitis

Sumitomo Pharma America, Inc.707 participantsStarted Nov 2008

Austin, Texas, United States • Kerrville, Texas, United States • New Braunfels, Texas, United States +1 more locations

COMPLETEDPhase 1< 1 mile

A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer

NCT01711034

The primary objective of this study is to determine the safe and tolerable dose level of OPB-111077 for patients with advanced cancer.

Solid Tumors

Otsuka Pharmaceutical Development & Commercialization, Inc.145 participantsStarted Jun 2012

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

NCT01456195

The purpose of this study is to determine the efficacy and safety of TAK-875 (fasiglifam), once daily (QD), in participants with type 2 diabetes mellitus (T2DM).

Diabetes Mellitus, Type 2

Takeda421 participantsStarted Nov 2011

Dothan, Alabama, United States • Muscle Shoals, Alabama, United States • Goodyear, Arizona, United States +92 more locations

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis

A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

Find Trials by Condition in San Antonio

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

Niacin Plus Statin to Prevent Vascular Events

Medigus Ultrasonic Surgical Endostapler (MUSE) Registry

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Coenzyme Q10 in Huntington's Disease (HD)

Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Major Depressive Disorder With Mixed Features - Extension

Lurasidone Pediatric Pharmacokinetics Study

Cross-sectional Study for Identification and Description of Severe Asthma Patients

A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)